GME
88
5
NTAP
52
3
DHI
28
-11
COP
39
2
OMC
50
8
WU
30
2
VIX
54
-9
VTR
55
-2
AMGN
33
2
XEL
58
-7
SYY
47
-2
KEY
48
-12
OI
49
2
EMN
53
-7
PAYX
53
2
AIV
39
-2
STI
29
2
LMT
62
12
TDC
44
3
AMG
52
-2
GME
88
5
NTAP
52
3
DHI
28
-11
COP
39
2
OMC
50
8
WU
30
2
VIX
54
-9
VTR
55
-2
AMGN
33
2
XEL
58
-7
SYY
47
-2
KEY
48
-12
OI
49
2
EMN
53
-7
PAYX
53
2
AIV
39
-2
STI
29
2
LMT
62
12
TDC
44
3
AMG
52
-2
Financhill
Back

Kaival Brands Innovations Group Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
23

KAVL
Kaival Brands Innovations Group

Last Price:
$0.51
Seasonality Move:
252.62%
Buy
55

SWTX
SpringWorks Therapeutics

Last Price:
$46.19
Seasonality Move:
3.79%
Sell
23
Kaival Brands Innovations Group (KAVL) is a Sell

Is Kaival Brands Innovations Group a Buy, Sell or Hold?

  • The current Kaival Brands Innovations Group [KAVL] share price is $0.50. The Score for KAVL is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • KAVL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
SpringWorks Therapeutics (SWTX) is a Buy

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $44.72. The Score for SWTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KAVL Stock Price Chart

What is Kaival Brands Innovations Group's stock price today?

  • The Kaival Brands Innovations Group share price today is $0.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing buying pressure, which is a positive indicator for future bullish movement.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $44.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing slight buying pressure.

KAVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 39.01 Sell
Chaikin Money Flow: 29435 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.48 - 0.56) Sell
Bollinger Bands (100): (0.56 - 1.12) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 56.04 Buy
Chaikin Money Flow: 2284845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.02 - 46.3) Buy
Bollinger Bands (100): (35.77 - 50.31) Buy

KAVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.49 Buy
20-day SMA: 0.51 Sell
50-day SMA: 0.65 Sell
200-day SMA: 0.87 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.52 Sell
50-day EMA: 0.65 Sell
200-day EMA: 1.38 Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.21 Buy
20-day SMA: 40.1 Buy
50-day SMA: 47.62 Sell
200-day SMA: 39.25 Buy
8-day EMA: 41.29 Buy
20-day EMA: 41.4 Buy
50-day EMA: 43.31 Buy
200-day EMA: 40.9 Buy

Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $2.02 per share.

Kaival Brands Innovations Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):